NEW YORK, Sept. 6 (GenomeWeb News) - Avestha Gengraine Technologies, a bioinformatics company based in India, will help Ranbaxy Laboratories develop recombinant cell lines as part of a drug-discovery program, the companies said today.


Avestha Gengraine's research covers infectious diseases and degenerative and metabolic disorders.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The Atlantic reports that genetic counselors are coping with an influx of patients seeking advice on their direct-to-consumer genetic test results.

A small study finds differences between three genomic prostate cancer tests, Medscape reports.

In Nature this week: shared genetic architecture for asthma and allergic diseases, and more.

A survey of Canadians finds them to be divided on genetically modified food, the Ottawa Citizen reports.